Investors Sell Off Cooper Companies After Q3 Miss and Guidance Cut
Cooper Companies (COO) faced a sharp sell-off after its fiscal third-quarter sales fell short of Wall Street expectations, prompting the company to cut guidance. The underperformance was primarily attributed to destocking in the CooperVision segment, which missed estimates by 4.5%, according to William Blair analyst Steven Lichtman. The disappointment was compounded when Cooper Companies decided not to sell its CooperSurgical business as previously speculated, adding uncertainty for investors seeking a potential strategic shift or value realization from that division.
Tickers: $COO
Topics: Contact Lenses CooperSurgical Medtech